🏛️ Verified NIH Record • Updated 2025-06-11
Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease (NCT04088773)
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Children's Hospital Medical Center, Cincinnati
🩺 Plain-English Summary (8th-Grade Level)
This research study will evaluate if specific blood, stool and MRI tests can tell the difference between bowel wall inflammation without scarring and bowel wall inflammation with scarring that can cause bowel blockages requiring surgery.
Who can join: Review the eligibility criteria below.
Location: Emory/Children's Healthcare of Atlanta — Atlanta, Georgia
Age range: 8 Years to 70 Years
🧪 Interventions in This Study
- blood biomarkers (DIAGNOSTIC_TEST)
- stool biomarkers (DIAGNOSTIC_TEST)
- MRI imaging (DIAGNOSTIC_TEST)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- Emory/Children's Healthcare of Atlanta — Atlanta, Georgia
- Michigan Medicine — Ann Arbor, Michigan
- Mayo Clinic — Rochester, Minnesota
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Crohn Disease
- Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease — Lutherville, Maryland
- Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial — New Haven, Connecticut
- A Phase 2 Clinical Trial: Xanthohumol Metabolism and Signature (XMaS) in Crohn's Disease — Portland, Oregon
- Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) — Ottawa, Ontario
- A Long-term Extension Study of Ustekinumab in Pediatric Participants — Atlanta, Georgia
Explore by condition: All Crohn Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.